Role of nitric oxide in cardiovascular alterations

Sepsis

Volumn 4, Issue 2, 2001, Pages 99-109

  Preiser, J C ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Clinical study; Endotoxin; Inflammatory mediators; Myocardial function; Regional blood flow; Vascular responsiveness

Indexed keywords

ARGININE; CALCIUM ANTAGONIST; CANAVANINE; CITRULLINE; GLUCOCORTICOID; INTERFERON; INTERLEUKIN 1; LYSINE; N(G) METHYLARGININE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR;

CARDIOVASCULAR RESPONSE; CORONARY BLOOD VESSEL; CYTOKINE PRODUCTION; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN LOCALIZATION; REVIEW; SEPSIS; SEPTIC SHOCK; VASODILATATION;

EID: 0035004131     PISSN: 13850229     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011498619555     Document Type: Review

References (180)

1. G-methylargine hydrochloride (546C88) in patients with septic shock
2. Nitrogen oxide levels in patients after trauma and during sepsis
3. Nitric oxide indices in human septic shock
4. Nitric oxide (NO) production correlates with renal insufficiency and multiple organ dysfunction syndrome in severe sepsis
5. Circulating methemoglobin, nitrate and nitrite concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock
6. Elevated methemoglobin in patients with sepsis
7. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy
8. L-arginine: Nitric oxide pathway in endotoxemia and human septic shock
9. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway
10. Differential regulation of the constitutive and inducible nitric oxide synthase mRNA by lipopolysaccharide treatment in vivo in the rat
11. Interleukin 1 and endotoxin activate soluble guanylate cyclase in vascular smooth muscle
12. In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery
13. Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide
14. Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase
15. Lipopolysaccharide treatment in vivo induces widespread tissue expression of inducible nitric oxide synthase mRNA
16. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production
17. Nitric oxide mediates interferon-gamma-induced hyperpermeability in cultured human intestinal epithelial monolayers
18. Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous gram-negative infection
19. Role of nitric oxide in effects of tumor necrosis factor-α on microcirculation in the rat
20. Tumor necrosis factor is an endogenous mediator of the induction of nitric oxide synthase in endotoxin shock in the rat
21. Induction of a macrophage-like nitric oxide synthase in cultured rat aortic endothelial cells
22. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide
23. Endotoxin stimulates arginine transport in pulmonary artery endothelial cells
24. Role of nitric oxide in the hemodynamic changes of sepsis
25. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells
26. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cyclic GMP
27. Immediate release of a nitric oxide-like factor from bovine aortic endothelial cells by Escherichia-coli lipopolysaccharide
28. Endotoxin-induced nitric oxide production in pulmonary artery endothelial cells is regulated by cytokines
29. Selective inhibition of endothelium-dependent vasolidator capacity by escherichia coli endotoxemia
30. Endothelium-dependent relaxation is depressed at the macro- and microcirculatory levels during sepsis
31. Endothelial-dependent and independent responses in the thoracic aorta during endotoxic shock
32. EDRF and nitric oxide production in cultured endothelial cells: Direct inhibition by E. coli endotoxin
33. Effects of endotoxin in vivo on endothelial and smooth-muscle function in rabbit and rat aorta
34. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life
35. Escherichia coli endotoxin inhibits agonist-mediated cytosolic Ca2+ mobilization and nitric oxide biosynthesis in cultured endothelial cells
36. Nitric oxide. To block or enhance its production during sepsis?
37. Nitric oxide involvement in septic shock: Do human beings behave like rodents?
38. Compartmentalised inducible nitric-oxide synthase activity in septic shock
39. Human polymorphonuclear leukocytes lack detectable nitric oxide synthase activity
40. Evaluation of nitrite production by human monocyte-derived macrophages
41. Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway
42. Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes
43. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes
44. Nitric oxide synthase inhibition partially prevents decreased LV contractility during endotoxemia
45. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility
46. Induction and potential biological relevance of a Ca2+ -independent nitric oxide synthase in the myocardium
47. Nitric oxide synthase activities in human myocardium
48. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
49. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium
50. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia
51. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes: Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro
52. Induction of nitric oxide synthase gene by interleukin -1β in cultured rat cardiocytes
53. Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): Mechanisms of contractile depression by nitric oxide
54. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo
55. Depression of the inotropic action of isoprenaline by nitric oxide synthase induction in rat isolated hearts
56. Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation
57. Lipopolysaccharide depresses cardiac contractility and beta-adrenergic contractile response by decreasing myofilament response to Ca2+ in cardiac myocytes
58. Effect of nitric oxide synthase inhibition on myocardial contractility in anesthetized normal and endotoxemic dogs
59. Alterations in inotropy, nitric oxide and cyclic GMP synthesis, protein phosphorylation and ADP-ribosylation in the endotoxin-treated rat myocardium and cardiomyocytes
60. Shortening of cardiac action potentials in endotoxic shock in guinea pigs is caused by an increase in nitric oxide activity and activation of the adenosine triphosphate-sensitive potassium channel
61. Methylene blue increases myocardial function in septic shock
62. Methylene blue administration in septic shock: A clinical trial
63. 2 uptake after inhibition of EDRF/NO synthesis
64. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs
65. Nitric oxide causes dysfunction of coronary autoregulation in endotoxemic rats
66. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats
67. Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide
68. Endotoxin-induced myocardial dysfunction: Is there a role for nitric oxide?
69. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock
70. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle
71. Nitric oxide does not mediate lipopolysaccharide -induced myocardial depression in guinea pigs
72. Nitric oxide as a positive inotropic agent in isolated rat hearts
73. Echocardiographic and survival studies in mice undergoing endotoxic shock: Effects of genetic ablation of inducible nitric oxide synthase and pharmacologic antagonism of platelet-activating factor
74. Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism
75. The NO donor sodium nitroprusside reverses the negative effects on hepatic arterial flow induced by endotoxin and the NO synthase inhibitor L-NAME
76. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs
77. 2 delivery in septic dogs
78. Right ventricular overload causes the decrease in cardiac output after nitric oxide synthesis inhibition in endotoxemia
79. Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogs
80. G-Nitro-L-arginine-methyl ester on myocardial blood flow and left ventricular function in dogs
81. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs
82. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion
83. Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88
84. Tissue oxygenation and hemodynamic response to no synthase inhibition in septic shock
85. Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis
86. Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia
87. Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats
88. Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis
89. Nitric oxide synthase inhibition restores vasopressor effects of norepinephrine in ovine hyperdynamic sepsis
90. Effects of methylene blue on blood pressure and reactivity to norepinephrine in endotoxemic rats
91. Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin
92. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock
93. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: Effect of aminoguanidine
94. Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats
95. Endothelium-derived kinins account for the immediate response of endothelial cells to bacterial lipopolysaccharide
96. Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia
97. Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries
98. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen
99. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis
100. Effect of bacterial lipopolysaccharide on function of rat small femoral arteries
101. Activated macrophages depress the contractility of rabbit carotids via an L-arginine/nitric oxide-dependent effector mechanism
102. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide
103. Vascular effects of LPS in mice deficient in expression of the gene for inducible nitric oxide synthase
104. Inducible NO synthase activity in blood vessels and heart: New insight into cell origin and consequences
105. Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein
106. Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock
107. Decreased sensitivity to vasoconstrictors in aortic rings after acute exposure to nitric oxide
108. Arginine analogues inhibit responses mediated by ATP-sensitive K+ channels
109. ATP opening in the cardiovascular alterations of canine endotoxic shock
110. S-nitrosothiol formation in blood of lipopolysaccharide-treated rats
111. Inhibition of nitric oxide synthesis is detrimental during endotoxemia
112. Protective and pathological roles of nitric oxide in endotoxin shock
113. Protective effect of nitric oxide in an endotoxin-induced septic shock
114. N-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin
115. ω-amino-L-arginine-methyl ester) in a murine sepsis model
116. Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages
117. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages
118. Effect of anti-fungal imidazoles on mRNA levels and enzyme activity of inducible nitric oxide synthase
119. The mechanism of the inhibitory effect of polyamines on the induction of nitric oxide synthase: Role of aldehyde metabolites
120. Effects of nitric oxide in septic shock
121. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage
122. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock
123. L-canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats
124. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxaemia
125. L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia
126. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock
127. S-alkyl-L-thiocitrullines. Potent stereoselective inhibitors of nitric oxide synthase with strong pressor activity in vivo
128. Effect of L-lysine on nitric oxide overproduction in endotoxic shock
129. Spontaneous rearrangement of aminoalkylguanidines into mecaptoalkylgunaidines - A novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform
130. Improved vascular contractility and cellular energetics in the delayed phase of hemorrhagic shock by mercaptoethylguanidine, a novel inhibitor of the inducible isoform of nitric oxide synthase
131. Protective effects of mercaptoethylguanidine, a selctive inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat
132. Collagen-induced arthritis: Reversal by mercaptoethylguanidine, a novel anti-inflammatory agent with a combined mechanism of action
133. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase
134. Selective iNOS inhibition is superior to norepinephrine in the treatment of rat endotoxic shock
135. Inhibition of nitric oxide synthesis aggravates reperfusion injury after hepatic ischemia and endotoxemia
136. Effects of nitric oxide synthesis inhibition on mesenteric perfusion in young pigs
137. Role of nitric oxide in porcine liver circulation under normal and endotoxemic conditions
138. Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion
139. Effects of NO on blood flow distribution and oxygen extraction capabilities during endotoxic shock
140. Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6
141. Changes in regional hemodynamics after nitric oxide inhibition during ovine bacteremia
142. The effects of nitric oxide inhibition on regional hemodynamics during hyperdynamic endotoxemia
143. Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats
144. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia
145. Regional intestinal blood flow and nitric oxide synthase inhibition during sepsis in the rat
146. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans
147. The pulmonary effect of nitric oxide synthase inhibition following endotoxemia in a swine model
148. Effect of inhibition of NO synthase on vascular reactivity in a rat model of hyperdynamic sepsis
149. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock
150. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock
151. G-nitro-L-arginine-methyl-ester on cardiopulmonary function and biosynthesis of cyclooxygenase products in porcine endotoxemia
152. Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock
153. Treatment of septic shock in rats with nitric oxide synthase inhibitors and inhaled nitric oxide
154. Comparison of the hemodynamic effects of nitric oxide synthase inhibition and nitric oxide scavenging in endotoxemic sheep
155. Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia
156. Nitric oxide may upregulate in vivo hepatic protein synthesis during endotoxemia
157. Interleukin-1 and nitric oxide protect against tumor necrosis factor α-induced liver injury through distinct pathways
158. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia
159. Nitric oxide synthase induction and intestinal epithelial cell viability in rats
160. Effects of lipopolysaccharide on intestinal injury: Potential role of nitric oxide and lipid peroxidation
161. Decreased ileal muscle contractility and increased NOS II expression induced by lipopolysaccharide
162. Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin
163. The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase
164. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock
165. Arginine transport in human liver: Characterization and effects of nitric oxide synthase inhibitors
166. Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shock
167. Nitric oxide donor prevents hepatic and systemic perfusion decrease induced by endotoxin in anesthetized rabbits
168. Role of endothelium-derived relaxing factor in renal autoregulation in conscious dogs
169. Induction of nitric oxide synthase in human mesangial cells
170. The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat
171. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis
172. Effect of inhibition of nitric oxide synthase in acute renal failure due to endotoxin shock in dogs
173. Nitric oxide synthase inhibition during experimental sepsis improves renal excretory function in the presence of chronically increased atrial naturietic peptide
174. A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase
175. L-arginine pathway in the sepsis syndrome
176. Effects of a nitric oxide synthase inhibitor in humans with septic shock
177. Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock
178. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension
179. Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study
180. Endothelin-1 and blood pressure after inhibition of nitric oxide synthesis in human septic shock